70% percent of women report taking prescription medicine during pregnancy, yet only only 10% of FDA approved drugs have sufficient clinical data to determine their safety during pregnancy. Check out Kristin Tolbert’s recent article about the importance of considering pregnant women in clinical trials. #InclusiveClinicalResearch #ClinicalTrials #HealthEquity #PregnantWomen
Recent research is showing medical treatment for #pregnantwomen often relies on #clinicaldata from non-pregnant female patient populations.???Kristin Tolbert, Associate VP of Health Equity Strategy at Jumo Health